Tianshui Zhongxing Bio-Technology Co. Ltd. Class A

Tianshui Zhongxing Bio-Technology Co. Ltd. Class A

SSZSE:002772
9.45
CNY
-0.16
(-1.66%)
0.90EPS
12.44P/E
4.26BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.15
1.67
1.79
1.81
2.03
2.57
3.21
4.4
3.96
4.98
4.74
4.94
5.6
5.72
Basic EPS, GAAP
0.24
0.39
0.43
0.49
0.39
0.31
0.19
0.56
0.14
0.4
0.39
0.33
0.89
0.91
Free Cash Flow per Basic Share
-0.34
-0.09
0.09
-0.76
-0.81
-1.16
-0.85
0.03
-1.78
0.63
0.97
0.64
-0.15
- -
Dividend per Share
0.07
0.11
0.13
0.1
0.15
0.14
0.22
0.31
0.38
0.43
0.52
0.51
0.5
0.96
Book Value per Share
1.77
2.16
3.38
6.12
7.03
7.05
7.07
7.42
7.97
8.3
8.73
8.44
8.97
9.5
Tangible Book Value per Share
1.25
1.63
2.83
5.54
6.4
6.26
6.17
6.5
7.11
7.46
7.88
7.57
8.05
8.53
Basic Weighted Avg Shares
229
230
267
323
365
361
360
337
393
396
408
392
375
375
Sales/Revenue/Turnover
264
383
480
585
740
926
1,156
1,483
1,556
1,970
1,931
1,935
2,098
2,144
Operating Margin (%)
19.93
23.65
23.53
23.07
13.47
9.7
11.29
15.12
6.46
13.73
10.82
8.29
16.76
17.25
Depreciation Expense
35
43
55
68
91
143
191
224
257
275
269
287
315
- -
Net Income, GAAP
55
91
114
159
142
112
68
189
55
158
160
128
335
342
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.36
- -
Profit Margin (%)
20.74
23.7
23.85
27.09
19.23
12.08
5.92
12.74
3.53
8.04
8.26
6.62
15.96
15.97
Working Capital
151
212
254
1,208
1,643
1,045
1,416
1,362
2,259
1,593
1,199
1,116
1,971
2,111
LT Debt
292
386
298
463
1,052
1,029
1,864
1,855
2,331
1,622
1,075
1,060
1,969
2,327
Total Equity
407
498
1,038
2,292
2,635
2,632
2,602
2,732
3,251
3,385
3,436
3,319
3,534
3,563
Return on Invested Capital (%)
8.3
10.08
8.93
7.35
4.26
3.04
1.76
3.91
1.49
2.77
2.76
2.23
5.52
5.29
Return on Capital (%)
9.49
12.06
11.02
7.7
4.43
3.55
3.41
5.59
2.44
4.14
4.23
3.68
6.47
6.25
Return on Common Equity (%)
14.51
20.18
14.98
9.57
5.8
4.26
2.62
7.09
1.84
4.78
4.68
3.79
9.79
9.91

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
921
1,127
1,238
LT Borrowings
1,881
2,151
2,121
LT Finance Leases
88
205
206
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
393
375
375
Market Capitalization
5,737
5,973
4,257

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,403
3,881
3,806
Cash, Cash Equivalents & STI
1,803
2,206
2,014
Accounts Receivable, Net
43
37
35
Inventories
1,517
1,603
1,703
Total Current Liabilities
1,432
1,570
1,696
Payables & Accruals
- -
- -
- -
ST Debt
921
1,127
1,238
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.73%
5.54%
6.49%
Free Cash Flow
-885.16%
-1,529.39%
-122.28%
Net Income, GAAP
40.42%
51.96%
161.63%
Sales/Revenue/Turnover
16.5%
7.64%
8.43%
Total Cash Common Dividend
21.31%
14%
-6.28%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
487
428
502
519
1,935
2025
473
435
- -
623
2,098
2026
602
483
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
-0.01
0.15
0.1
0.33
2025
0.13
0.06
- -
0.35
0.89
2026
0.43
0.08
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.16
0.05
0.05
0.51
2025
0.04
0.35
- -
0.05
0.5
2026
0.2
0.35
- -
- -
- -

Company Description

CEO
Liang Liu
Full Time Employees
9,181
Sector
Consumer non-durables
Industry
Food: specialty/candy
Address
Tianshui National Agricultural Science & Tianshui GA China 741030
IPO Date
Jun 26, 2015
Website
tszxjy.cn
Business
Tianshui Zhongxing Bio-technology Co.,Ltd. Tianshui Zhongxing Bio-technology Co.,Ltd. is a China-based company principally engaged in the research, development, factory cultivation, and sale of edible fungi products. The company offers flammulina velutipes (enoki mushrooms) under brands including Xihuang, Nuwa, Xuebai, and Junfu; agaricus bisporus (bisporus mushrooms) under the Zhongxing brand; and cordyceps sinensis mushrooms, along with related packaging solutions; it also pursues agriculture planting, investment management, and real estate development activities. Founded in 2005 and headquartered in Tianshui, Gansu Province, the company follows a global production strategy centered in northwest China while expanding domestically and internationally, targeting consumers with green, safe, high-quality fungus products backed by modern biotechnology. In recent developments, Tianshui Zhongxing unveiled a 2025 Stock Option Incentive Plan, adjusted its equity structure in subsidiary Sichuan Zhongxing Bio-technology Co., Ltd. to hold 71% ownership while allocating 29% to management and technical personnel, and plans to invest 700 million yuan in the Southwest Headquarters Base Project for the edible and medicinal mushroom industry in partnership with Jintang County authorities; additionally, it implemented a 2024 dividend of 3 yuan per 10 shares.